Sepsis-3: Insights from the Lead Author

Rodzaj pokoju

Permanentny

Imię

To pole jest wymagane.

Nazwisko

To pole jest wymagane.

Adres email

To pole jest wymagane.

Firma

To pole jest wymagane.

Pola wymagane

Płatność przez

Zanim kupisz bilet, zapoznaj się tutaj z wymaganiami technicznymi niezbędnymi, by dołączyć do wydarzenia.

Jeśli już zarejestrowałaś/łeś się na to spotkanie, a nie otrzymałaś/łeś maila z potwierdzeniem, kliknij tutaj!

Test konfiguracji systemu. Kliknij tutaj!

Marvyn Singer, MD

Mervyn Singer, MB BS, MD, FRCP (Lon), FRCP (Edin), FFICM, is Professor of Intensive Care Medicine and Director of the Bloomsbury Institute of Intensive Care Medicine at University College London, UK, since 2001. He was Senior Investigator at the National Institute of Health Research from 2009 to 2017 and is currently the Sepsis Topic Advisor for NICE. Dr Singer was Co-chair of the Sepsis-3 Consensus Task Force and lead author of "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Plan wydarzenia

This special session features Dr. Mervyn Singer, lead author of Sepsis-3 guidelines and co-author of the new update to SOFA, SOFA-2.

In this session, Dr. Singer:

Outlines why the Sepsis-2 SIRS criteria are now regarded as outdated and inadequate.
Describes the development process of the Sepsis-3 guidelines.
Discusses the latest revisions to the SOFA score, known as SOFA-2.
Debunks the common sepsis denial rationales presented by payers.

Recording is available for 90 days after purchase.